Revenue
2018
2019
2020
2021
2022
2023
2024
2025
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | — | — | — | — | — | $4.22B | $4.10B | $4.12B | $3.90B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | $3.42B | $3.34B | $3.35B | $3.33B | $3.21B | $3.10B | $3.12B | $3.02B |
| Research & development | $458.5M | $437.4M | $458.7M | $406.0M | $435.8M | $322.8M | $449.3M | $391.7M | $369.9M | $365.6M | $268.8M | $187.4M | $203.0M | $225.6M | $238.4M | $218.5M | $205.7M | $192.3M | $182.6M |
| Operating expenses | — | — | — | — | — | — | — | — | — | — | $5.53B | $3.64B | $3.55B | $2.30B | $2.31B | $2.29B | $2.09B | $2.03B | $1.89B |
| Operating income | $1.10B | $1.29B | $1.28B | $696.3M | $860.3M | $83.1M | $1.14B | $33.8M | $799.3M | $821.1M | $467.3M | $1.04B | $1.07B | $1.05B | $1.02B | $916.7M | $1.02B | $1.09B | $1.13B |
| EBITDAderived | $2.19B | $2.28B | $2.23B | $1.62B | $1.80B | $981.5M | $2.14B | $1.07B | $1.86B | $1.86B | $1.18B | $1.41B | $1.43B | $1.41B | $1.38B | $1.26B | $1.36B | $1.37B | $1.36B |
| Net income | $705.1M | $903.8M | $1.02B | $231.4M | $401.6M | −$138.9M | $1.13B | −$379.2M | $1.81B | $305.9M | $147.0M | $720.3M | $780.4M | $755.0M | $760.8M | $596.9M | $717.4M | $848.6M | $773.2M |
| Basic EPSper diluted share | $3.56 | $4.45 | $4.91 | $1.10 | $1.93 | -$0.67 | $5.52 | -$1.86 | $8.98 | $1.53 | $0.78 | $4.26 | $4.60 | $4.32 | $4.05 | $2.98 | $3.34 | $3.73 | $3.28 |
| Diluted EPSper diluted share | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | -$0.67 | $5.47 | -$1.86 | $8.90 | $1.51 | $0.77 | $4.20 | $4.54 | $4.29 | $4.03 | $2.97 | $3.32 | $3.72 | $3.26 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026Form 4 | Yi SangGroup President, Asia Pacific | SellCommon Stock | 800 | $82.66 | $66.1K | 27.3K |
| May 29, 2026Form 4 | Yi SangGroup President, Asia Pacific | SellCommon Stock | 4.2K | $82.64 | $347.1K | 28.1K |
| Mar 12, 2026Form 4 | Winkler LoriSVP and CHRO | SellCommon Stock | 2.6K | $94.66 | $250.8K | 10.2K |
| Feb 12, 2026Form 4 | Yi SangGroup President, Asia Pacific | SellCommon Stock | 1.0K | $96.49 | $96.5K | 17.7K |
| Sep 11, 2025Form 4 | Yi SangGroup President, Asia Pacific | SellCommon Stock | 1.2K | $103.59 | $124.3K | 18.6K |